VKTX vs VRDN Stock Comparison
VRDN currently leads VKTX in this stock comparison, with AIQ scores of 58 vs 41. The clearest difference is momentum.
What is the main difference between VKTX and VRDN?
VRDN leads the current stock comparison as Viridian Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Viking Therapeutics, Inc. vs Viridian Therapeutics, Inc.
VRDN leads
VRDN leads by 17 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 21 points over 30 sessions. Wall Street currently favors VKTX on target upside.
Stable: 4 of 5 evidence groups support VRDN, its lead is narrowing, and its current signal state is conflicted.
Viking Therapeutics, Inc.
Viridian Therapeutics, Inc.
The Algovestiq AIQ Score currently favors VRDN over VKTX, 58 versus 41 as of Nov 15, 2026. VRDN's advantage is driven primarily by stronger momentum and quality. VRDN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors VKTX. 4 of 5 covered evidence groups favor VRDN today, and the comparison is rated Stable on stability: the leader's advantage has been narrowing. VRDN lead: Weakening — the AIQ differential moved from 21 to 17 points over 30 sessions.
Compare Viking Therapeutics, Inc. and Viridian Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare VKTX and VRDN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum47 vs 91VRDN +44
- Quality33 vs 41VRDN +8
- Risk Resilience41 vs 46VRDN +5
4 of 5 evidence groups favor VRDN. VRDN’s edge is concentrated in momentum and quality.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +3
New signals
- Accumulation Pattern — bullish, volume, medium horizon (2.11x)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Midline Reclaim — bullish, momentum, short horizon
Largest factor move: Quality +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 9 active signals are unchanged.
VRDN's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — VKTX and VRDN both carry a full feed there.
The central trade-off
VRDN (Viridian Therapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.
VKTX (Viking Therapeutics, Inc.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
VRDNVRDN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
VRDNVRDN on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
VRDNVRDN on the Momentum factor, by 44 points.
Lower downside
VRDNVRDN on Risk Resilience, by 5 points.
Analyst upside
VKTXVKTX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors VRDN, analyst targets favor VKTX. That disagreement is the most useful thing on this page.
| Measure | VKTX | VRDN | Note |
|---|---|---|---|
| Implied upside to target | +172.6% | +31.2% | VKTX has more room |
| Target dispersion | +107.9% | +12.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 21 | 17 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 5 covered evidence groups favor VRDN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | VRDN | 41 vs 58 |
| Fundamentals | VRDN | EPS growth -40.9% vs 22.9%; TTM ROE -31.1% vs -17.4% |
| Valuation | Not covered | Not covered |
| Technicals | VRDN | Price vs 50-day -0.4% vs 35.7%; vs 200-day -9.2% vs 43.2% |
| Risk Resilience | VRDN | Risk Resilience 41 vs 46 |
| Analyst expectations | VKTX | Target upside 172.6% vs 31.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of VKTX and VRDN and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 17 points. (supports the conclusion holding)
- 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on VRDN.
How the comparison changed
120 daily snapshots · May 27 – Nov 13VRDN lead: Weakening — the AIQ differential moved from 21 to 17 points over 30 sessions.
- Today
- VRDN +17
- 41 vs 58
- 7 sessions ago
- VRDN +17
- 39 vs 56
- 30 sessions ago
- VRDN +21
- 35 vs 56
- 90 sessions ago
- VKTX +2
- 49 vs 47
The lead changed hands 2 times in this window, most recently on Sep 4 when VRDN moved ahead of VKTX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 3 bearish / 1 neutral, conflicted
Only VKTX
- Death Cross Active — bearish, trend, long horizon (9.70%)
- Accumulation Pattern — bullish, volume, medium horizon (2.11x)
- Beta Spike Warning — bearish, risk_regime, long horizon
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Midline Reclaim — bullish, momentum, short horizon
- Volume Surge - Bullish — bullish, volume, short horizon (2.11x)
5 bullish / 2 bearish / 2 neutral, conflicted
Only VRDN
- Golden Cross Active — bullish, trend, long horizon (5.52%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.42x)
- RSI Overbought — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
VRDN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +5.95%, AIQ +2 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.28%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1VKTX closes the Momentum gap — currently 44 points behind, the largest single contributor to VRDN's edge.
- 2VKTX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3VRDN's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 17-point move would eliminate VRDN's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
VRDN leads on balance| Metric | VKTX | VRDN |
|---|---|---|
| Revenue growth (YoY) | 0% | 89.7% |
| EPS growth (YoY) | -40.9% | 22.9% |
| Gross margin | 0% | 93% |
| Operating margin | 0% | -17.8% |
| Return on equity (TTM) | -31.1% | -17.4% |
| Debt to equity | 0.43 | 0.42 |
Performance
VRDN leads 5 of 6 windows| Metric | VKTX | VRDN |
|---|---|---|
| 1 week (5 sessions) | 8.9% | 8.4% |
| 1 month (20 sessions) | 16.1% | 62.2% |
| 3 months (63 sessions) | -13.1% | 33.7% |
| 6 months (126 sessions) | -3.5% | 83.5% |
| Year to date | -16.9% | -0.8% |
| 1 year (252 sessions) | -28.3% | 6.7% |
Technicals
VRDN has the stronger structure| Metric | VKTX | VRDN |
|---|---|---|
| RSI (14) | 55 | 77.3 |
| ADX (14) | 13.7 | 51 |
| Price vs 50-day | -0.4% | 35.7% |
| Price vs 200-day | -9.2% | 43.2% |
| Volatility (1M, annualized) | 69.7% | 69.7% |
Risk
VRDN is the more resilient| Metric | VKTX | VRDN |
|---|---|---|
| Beta | 1.29 | 1.14 |
| Sharpe ratio | -0.15 | 0.43 |
| Sortino ratio | -0.25 | 0.62 |
| Max drawdown | -42.5% | -60.6% |
| Current drawdown | -30.6% | -8.6% |
| Annualized volatility | 69.2% | 72% |
| Value at risk (95%) | -5.6% | -4.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, VKTX or VRDN?
On the Algovestiq AIQ Score, VRDN is the stronger of the two as of Nov 15, 2026, scoring 58 against VKTX's 41. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is VKTX or VRDN the better buy right now?
VRDN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor VRDN over VKTX?
The composite weights Quality, Value, Momentum and Risk Resilience. VRDN leads Momentum by 44 points; VRDN leads Quality by 8 points; VRDN leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, VKTX or VRDN?
Analyst price targets imply +172.6% upside for VKTX and +31.2% for VRDN, so the Street currently favors VKTX. That points the opposite way to the AIQ Score, which favors VRDN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, VKTX or VRDN?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, VKTX or VRDN?
VRDN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, VKTX or VRDN?
VRDN on the Momentum factor, by 44 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, VKTX or VRDN?
VRDN is the more resilient of the two, so the other name carries the higher downside risk. VRDN on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is VKTX more profitable than VRDN?
VRDN leads on the comparable margin measures — gross margin 0% vs 93%; operating margin 0% vs -17.8%; ttm roe -31.1% vs -17.4%.
Is VRDN's lead over VKTX getting stronger or weaker?
VRDN lead: Weakening — the AIQ differential moved from 21 to 17 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-09-04, when VRDN moved ahead of VKTX.
What would change the VKTX vs VRDN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: VKTX closes the Momentum gap — currently 44 points behind, the largest single contributor to VRDN's edge; VKTX's Death Cross Active resolves — a bearish trend rule currently active against it; VRDN's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 17-point move would eliminate VRDN's advantage entirely.
What do the current signals say about VKTX and VRDN?
VKTX: 4 bullish / 3 bearish / 1 neutral, conflicted. VRDN: 5 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on VKTX is Death Cross Active (bearish, long horizon). On VRDN it is Golden Cross Active (bullish, long horizon).
Compare VKTX and VRDN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.